Ingersoll Rand Acquires Scinomix, Expanding Its Life Sciences Portfolio; Terms Not Disclosed

Benzinga · 01/05 21:34
  • Bolt-on acquisition supports the company's growth strategy with scalable opportunities for innovation and market expansion within life sciences
  • Enables Ingersoll Rand to provide more comprehensive solutions using technologies that help streamline workflows with greater automation and increased accuracy for customers
  • Adds another founder-owned company to the Ingersoll Rand portfolio and highlights the ability to identify and cultivate acquisitions on a proprietary basis
  • Investment made at attractive pre-synergy purchase multiple of approximately 10x 2025 Adjusted EBITDA
     

DAVIDSON, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc., (NYSE:IR) a global provider of mission-critical flow creation and life science and industrial solutions, has acquired Scinomix, Inc., expanding the company's life sciences portfolio.